Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis

BACKGROUND: Given recent discrepant results from randomized controlled trials (RCTs), we examined the totality of RCT evidence assessing the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and heart failure. METHODS: MEDLINE, Embase and ClinicalTrials.gov were searched without language...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:CMAJ Open
Auteurs principaux: Verma, Subodh, Goldenberg, Ronald M., Bhatt, Deepak L., Farkouh, Michael E., Quan, Adrian, Teoh, Hwee, Connelly, Kim A., Leiter, Lawrence A., Friedrich, Jan O.
Format: Artigo
Langue:Inglês
Publié: Joule Inc. or its licensors 2017
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403656/
https://ncbi.nlm.nih.gov/pubmed/28459046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20160058
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires